These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28478548)

  • 1. Apparent biochemical thyrotoxicosis due to assay interference by high-dose biotin given for multiple sclerosis.
    Cusini C; Sassi L; De Paola G; Piantanida E
    J Endocrinol Invest; 2017 Aug; 40(8):889-890. PubMed ID: 28478548
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apparent thyrotoxicosis in a patient with multiple sclerosis: biochemical assay interference due to high dose biotin use].
    van den Berg R; Slim CL; Lutgers HL; de Heide LJM; Wolthuis A
    Ned Tijdschr Geneeskd; 2018 Feb; 162():. PubMed ID: 30730120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotin Interference in the Measurement of Thyroid Hormone.
    Koehler VF; Mann U; Mann WA
    Dtsch Arztebl Int; 2018 Jul; 115(29-30):500. PubMed ID: 30135010
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotin in multiple sclerosis and false biological hyperthyroidism: Mind the interference.
    Willeman T; Casez O; Faure P
    Rev Neurol (Paris); 2017 Mar; 173(3):173-174. PubMed ID: 28302321
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to letter to the editors.
    Birnbaum G; Stulc J
    Mult Scler Relat Disord; 2018 May; 22():86. PubMed ID: 29626803
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intake of high dose biotin: A cause of artificial hyperthyroidism].
    Bouillet B; Rouland A
    Rev Med Interne; 2020 Feb; 41(2):123-125. PubMed ID: 31813616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe transient myopathy in a patient with progressive multiple sclerosis and high-dose biotin.
    Maillart E; Mochel F; Acquaviva C; Maisonobe T; Stankoff B
    Neurology; 2019 May; 92(22):1060-1062. PubMed ID: 31028130
    [No Abstract]   [Full Text] [Related]  

  • 8. Intersections of pathways involving biotin and iron relative to therapeutic mechanisms for progressive multiple sclerosis.
    Heidker RM; Emerson MR; LeVine SM
    Discov Med; 2016 Dec; 22(123):381-387. PubMed ID: 28147220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoassay interference secondary to therapeutic high-dose biotin: A paediatric case report.
    Evans N; Yates J; Tobin J; McGill J; Huynh T
    J Paediatr Child Health; 2018 May; 54(5):572-575. PubMed ID: 29405469
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis.
    Sedel F; Bernard D; Mock DM; Tourbah A
    Neuropharmacology; 2016 Nov; 110(Pt B):644-653. PubMed ID: 26327679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotin: From Nutrition to Therapeutics.
    Mock DM
    J Nutr; 2017 Aug; 147(8):1487-1492. PubMed ID: 28701385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose biotin as treatment for progressive multiple sclerosis.
    Birnbaum G; Stulc J
    Mult Scler Relat Disord; 2017 Nov; 18():141-143. PubMed ID: 29141796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference.
    Piketty ML; Prie D; Sedel F; Bernard D; Hercend C; Chanson P; Souberbielle JC
    Clin Chem Lab Med; 2017 May; 55(6):817-825. PubMed ID: 28222020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferences of biotin therapy on immunoassays: It is time for a long-term solution!].
    Denimal D; Nguyen A; Fromont A; Moreau T; Vergès B; Duvillard L
    Presse Med; 2018 Jan; 47(1):95-97. PubMed ID: 29275027
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotin induced biochemical hyperthyroidism: a case report and review of the literature.
    James A; Stalan J; Kuzhively J
    J Med Case Rep; 2023 Jun; 17(1):266. PubMed ID: 37370185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial.
    Singer GM; Geohas J
    Diabetes Technol Ther; 2006 Dec; 8(6):636-43. PubMed ID: 17109595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fake news? Biotin interference in thyroid immunoassays.
    Koehler VF; Mann U; Nassour A; Mann WA
    Clin Chim Acta; 2018 Sep; 484():320-322. PubMed ID: 29856977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassurance on the safety of biotin in dermatology.
    Piraccini BM
    G Ital Dermatol Venereol; 2018 Dec; 153(6):877. PubMed ID: 30518178
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotin at High Concentration Interferes with the LOCI Digoxin Assay but the PETINIA Phenytoin Assay Is Not Affected.
    Rodriguez JJ; Acosta F; Bourgeois L; Dasgupta A
    Ann Clin Lab Sci; 2018 Mar; 48(2):164-167. PubMed ID: 29678842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A caution regarding high-dose biotin therapy: misdiagnosis of hyperthyroidism in euthyroid patients.
    Trambas CM; Sikaris KA; Lu ZX
    Med J Aust; 2016 Aug; 205(4):192. PubMed ID: 27510354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.